
The Wall Street Journal @WSJ
An experimental drug from Eli Lilly failed to prevent memory loss in a study of healthy older people with a high risk of developing clinical Alzheimer’s disease in one of the first studies aimed at stopping symptoms before they start https://t.co/AhajTm34Wd — PolitiTweet.org